Taxotere is a chemotherapy drug used to treat women with breast cancer. Although temporary hair loss is a common side effect of chemotherapy, Taxotere has been linked to permanent hair loss, also known as Permanent Significant Alopecia (PSA). It is believed that Sanofi, the manufacturer of the drug, knew that Taxotere was linked to permanent hair loss and failed to warn doctors and patients about that risk. As such, patients and their physicians did not have the option to chose other chemotherapy agents that do not cause permanent hair loss. If you or a loved one has suffered permanent hair loss after exposure to Taxotere during treatment for breast cancer, please give us a call for a free case review.